Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02098837
What this trial is testing

Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)

Who this might be right for
HIV
St Stephens Aids Trust 415
Post-approval studies (Phase 4)UnknownNCT00011895
What this trial is testing

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
GlaxoSmithKline 400
Not applicableStudy completedNCT00516581
What this trial is testing

Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART

Who this might be right for
HIV
UPECLIN HC FM Botucatu Unesp 376
Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Large-scale testing (Phase 3)Study completedNCT01825031
What this trial is testing

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus
Anna Griffiths, MRC 1,805
Large-scale testing (Phase 3)Study completedNCT03480802
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 302
Post-approval studies (Phase 4)Study completedNCT00317902
What this trial is testing

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

Who this might be right for
AnemiaHIV Infections
Ortho Biotech Products, L.P. 292
Testing effectiveness (Phase 2)Study completedNCT00246363
What this trial is testing

A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C

Who this might be right for
HIV InfectionsHepatitis C
Henry Sacks 40
Not applicableUnknownNCT06279819
What this trial is testing

Effectiveness of Gut Microbiota-targeted Dietary Intervention Among HIV-infected Patients

Who this might be right for
HivCardiovascular DiseasesDiet, Healthy
Fudan University 106
Early research (Phase 1)Study completedNCT04006704
What this trial is testing

Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo Tablets

Who this might be right for
HIV-1
Janssen Pharmaceutica N.V., Belgium 25
Early research (Phase 1)Looking for participantsNCT07481175
What this trial is testing

Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study)

Who this might be right for
HIV-1
Thomas Aagaard Rasmussen 38
Testing effectiveness (Phase 2)Study completedNCT00080106
What this trial is testing

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Testing effectiveness (Phase 2)Study completedNCT00257621
What this trial is testing

GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 30
Not applicableUnknownNCT03860116
What this trial is testing

Evaluation of a Smart Phone App-based Case Management Model Among ART-naive HIV-infected MSM

Who this might be right for
HIV/AIDS
Sun Yat-sen University 600
Testing effectiveness (Phase 2)Study completedNCT00976404
What this trial is testing

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Who this might be right for
HIV Infection
Robert L. Murphy 28
Not applicableStudy completedNCT00000873
What this trial is testing

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,400
Not applicableStudy completedNCT01917994
What this trial is testing

Text Messaging Intervention to Improve Retention in Care and Virologic Suppression in an Urban HIV-Infected Population

Who this might be right for
HIVPatient AdherenceMobile Technology
University of California, San Francisco 230
Large-scale testing (Phase 3)Ended earlyNCT03333083
What this trial is testing

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen

Who this might be right for
HIV SeropositivityHIV InfectionsHIV-1-infection
Judit Pich 17
Testing effectiveness (Phase 2)Study completedNCT00000641
What this trial is testing

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT00006441
What this trial is testing

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 398
Next Page